The immediate ATM facility is a strong signal that Tenon needs cash urgently, likely to fund operations and address Nasdaq listing requirements. Expect heavy selling pressure as shares are dumped into the market. Monitor for the first ATM sales on the tape.
Price Chart
Executive Summary
Tenon Medical filed a universal shelf registration statement (S-3) to register up to $100M in securities, including an immediate ATM facility for up to ~$4.4M of common stock via A.G.P. The filing comes just one day after a 1-for-35 reverse stock split intended to regain Nasdaq bid-price compliance. The company's most recent 10-Q (March 31, 2026) showed a net tangible book value of negative ~$982K, a working capital deficit, and the auditor's going-concern opinion. This shelf provides the financial flexibility to raise capital, but the ATM's immediate availability signals an urgent need for cash, and the massive potential dilution (the ATM alone could increase the share count by over 100%) is highly bearish for existing common stockholders.
Key Financial Metrics
Key Facts
- Tenon filed an S-3 shelf registration for up to $100M in securities, including an immediate ATM facility for up to $4,397,821 in common stock.
- The ATM is with A.G.P./Alliance Global Partners, with a 3.0% commission on gross proceeds.
- As of August 10, 2026, the public float was $13.2M (606,596 shares), and the stock price was $6.05 after a 1-for-35 reverse split.
- The company's most recent 10-Q (March 31, 2026) showed a net tangible book value of negative ~$982,000 and a going-concern warning from its auditor.
- The company has a history of frequent dilutive offerings (17 offering/registration filings in the last 24 months).
Financial Impact
The ATM alone could raise up to $4.4M, but at the current ~$6.05 price, it would require issuing ~727K new shares, more than doubling the pre-split share count of 667K. The $100M shelf represents a massive overhang relative to the $72M market cap.
Risk Factors
- Massive dilution from the ATM and potential future offerings under the $100M shelf.
- Nasdaq delisting risk remains if the company fails to maintain compliance with bid price and stockholders' equity rules.
- Going-concern risk as highlighted by the auditor, with negative tangible book value and a history of cash burn.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| S-3 Filing (TNON) — Batch item 1 | 0001213900-26-087891 |
| Document: ea029490601ex4-2.htm | 0001213900-26-087891 |
| S-3 Filing (TNON) — Batch item 3 | 0001213900-26-087891 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 22, 2026 3d ago | 8-K | $2.25 | awaiting T+20 | — | $2.11 (−6.22%) |
Oct 16, 2026 9d ago | 424B5 | $2.45 | awaiting T+20 | — | $2.11 (+13.88%) |
Oct 13, 2026 13d ago | EFFECT | $2.89 | awaiting T+20 | — | $2.11 (+26.99%) |
Oct 9, 2026 16d ago | 3 | $2.98 | awaiting T+20 | — | $2.11 (−29.19%) |
Sep 16, 2026 5w ago | 8-K | $4.20 $2.91 | ▲ +30.71% | ▲ +31.92% | $2.11 (+49.76%) |
Sep 11, 2026 6w ago | Insider Buy | $5.93 $3.41 | ▼ −42.50% | ▼ −44.36% | $2.11 (−64.42%) |
Sep 9, 2026 6w ago | 8-K | $2.44 $3.50 | ▲ +43.44% | ▲ +41.50% | $2.11 (−13.52%) |
Sep 1, 2026 7w ago | Insider Buy | $4.47 $4.04 | ▲ +9.62% | ▲ +9.71% | $2.11 (+52.80%) |
Aug 31, 2026 7w ago | 8-K | $4.53 $2.73 | ▲ +39.74% | ▲ +39.55% | $2.11 (+53.42%) |
Aug 31, 2026 7w ago | 3 | $4.53 $2.73 | ▼ −39.74% | ▼ −39.55% | $2.11 (−53.42%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers